InvestorsHub Logo

BottomBounce

09/16/21 8:52 AM

#31608 RE: TRAPPER JIM #31607

$IBIO The company also highlighted that it has entered into a research services agreement with FairJourney Biologics to gain access to novel display technologies and proprietary antibody libraries.
FairJourney is a biologics CRO, providing integrated services across antibody discovery, engineering and production to global biopharma.
"Our experience in antibody discovery for use in oncology has grown in recent years, with a number of undisclosed collaborations rapidly moving towards the clinic," António Parada, CEO at FairJourney said. https://seekingalpha.com/news/3713810-ibio-establishes-oncology-drug-discovery-pipeline-three-new-antibody-programs